论文部分内容阅读
目的:观察巴曲酶(商品名:东菱迪芙)治疗椎基底动脉系统脑梗死的疗效。方法:随机选择椎基底动脉系统脑梗死患者51例为治疗组,应用东菱迪芙首次10BU加0.9%氯化钠溶液100ml静脉滴注1h,以后隔日1次,5BU/次,共3次;对照组51例应用低分子肝素钙5000U脐周皮下注射,每天2次,连用10d。治疗前后监测Fg、PT、APTT、PLT。结果:治疗后2组间总有效率、显效率相比均有统计学意义(P<0.01),治疗组优于对照组;治疗组Fg降低,但未见明显出血等不良反应。结论:东菱迪芙治疗椎基底动脉系统脑梗死安全、有效。
Objective: To observe the curative effect of batroxobin (trade name: Dong Ling Duff) in treating vertebrobasilar cerebral infarction. Methods: Totally 51 patients with vertebrobasilar cerebral infarction were selected as the treatment group. The first 10 U of 10B U plus 0.9% sodium chloride solution was infused intravenously for 1 h and then every other day for 5 times. Control group of 51 cases of low molecular weight heparin 5000U umbilical subcutaneous injection, 2 times a day, once every 10d. Before and after treatment monitoring Fg, PT, APTT, PLT. Results: After treatment, the total effective rate and markedly effective rate were statistically significant (P <0.01). The treatment group was better than the control group. The treatment group had lower Fg, but no obvious bleeding and other adverse reactions. Conclusion: Donglingdufu treatment of vertebrobasilar cerebral infarction system is safe and effective.